Specific death of ALT cells through TSPYL5 depletion

Eloïse Claude1, Harikleia Episkopou1, Anabelle Decottignies1

  • 1Genetic and Epigenetic Alterations of Genomes, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Insights

Testis-Specific Y-encoded-Like Protein 5 (TSPYL5) is crucial for maintaining the viability of Alternative Lengthening of Telomeres (ALT) cancer cells. TSPYL5 protects Protection Of Telomeres 1 (POT1) from degradation, offering potential new therapeutic targets for ALT-driven tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Alternative Lengthening of Telomeres (ALT) is a telomere maintenance mechanism enabling replicative immortality in some cancers.
  • The ALT pathway bypasses telomerase, presenting unique therapeutic vulnerabilities.
  • Currently, specific molecular targets for ALT-driven cancers remain largely unknown.

Purpose of the Study:

  • To identify novel molecular targets within the ALT pathway.
  • To investigate the role of TSPYL5 (Testis-Specific Y-encoded-Like Protein 5) in ALT-driven cancer cell viability.
  • To elucidate the mechanism by which TSPYL5 influences telomere maintenance.

Main Methods:

  • Analysis of TSPYL5 expression in ALT-positive cancer cells.
  • Investigating the interaction between TSPYL5 and POT1 (Protection Of Telomeres 1).
  • Assessing the impact of TSPYL5 modulation on cell viability and telomere length.

Main Results:

  • TSPYL5 was found to be essential for the viability of ALT cells.
  • TSPYL5 directly binds to and protects POT1 from proteasomal degradation.
  • Inhibition of TSPYL5 leads to POT1 destabilization and impaired ALT function.

Conclusions:

  • TSPYL5 plays a critical role in maintaining ALT cell survival by stabilizing POT1.
  • TSPYL5 represents a potential therapeutic target for cancers utilizing the ALT pathway.
  • Targeting TSPYL5 could offer a novel strategy to combat ALT-driven tumors.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.9K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K